WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.

WW International, the company known as WeightWatchers, brought back its full-year outlook when it reported second-quarter ...

Under the agreement, Weight Watchers (OTC:WGHTQ), which filed for Chapter 11 bankruptcy protection in May, will work with Humana’s (NYSE: HUM) CenterWell Pharmacy to sell Wegovy through the ...

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

Ozempic and Wegovy were first prescribed to treat type 2 diabetes but have surged in popularity as a weight loss drug. Semaglutide, the main ingredient in the drugs, helps suppress a user's ...

"So this is not just the weight loss, it's also health indicators." The price of these drugs, however, remains high. On average, they can cost over $1,000 out of pocket.

Weight Watchers said in March that it would be acquiring the telehealth platform Sequence, which will give calorie counters access to subscription-based weight-loss drugs like Ozempic, Wegovy and ...

As new therapies for obesity enter the market, biopharmaceutical companies will need to tune commercial strategies to win ...

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

WeightWatchers rolled up late to the knockoff Wegovy party, announcing on Tuesday that it would begin to sell a compounded version of Novo Nordisk blockbuster weight loss drug.

Wegovy (semaglutide) is a long-term treatment for weight loss. How long you take the drug depends on how well you tolerate its side effects and whether it’s safe for you.